Abstract
In multicellular organisms, unnecessary or harmful cells, such as those that are cancerous or infected with a virus, are eliminated by apoptosis. After apoptosis, cell corpses are rapidly recognized and phagocytosed by professional phagocytes, such as macrophages and dendritic cells. The rapid removal of cell corpses by phagocytes prevents the release of potentially toxic or immunogenic materials from dying cells. Although a number of molecules on phagocytes have been found to be involved in apoptotic cell clearance in vitro, only a few have been proved to be involved in apoptotic cell clearance in vivo by analyses of knockout animals. These knockout mice commonly suffer from autoimmunity, indicating that the complete removal of apoptotic cells is essential for the maintenance of selftolerance. In this review, we present an overview of the molecular mechanisms of apoptotic cell clearance by phagocytes and the pathological relevance of the failure of apoptotic cell clearance to autoimmune disorder.
Keywords: Apoptosis, phagocytosis, macrophage, dendritic cell, autoimmune disease, self-tolerance
Current Medicinal Chemistry
Title: Apoptotic Cell Clearance and Autoimmune Disorder
Volume: 14 Issue: 27
Author(s): Masato Tanaka and Yasunobu Miyake
Affiliation:
Keywords: Apoptosis, phagocytosis, macrophage, dendritic cell, autoimmune disease, self-tolerance
Abstract: In multicellular organisms, unnecessary or harmful cells, such as those that are cancerous or infected with a virus, are eliminated by apoptosis. After apoptosis, cell corpses are rapidly recognized and phagocytosed by professional phagocytes, such as macrophages and dendritic cells. The rapid removal of cell corpses by phagocytes prevents the release of potentially toxic or immunogenic materials from dying cells. Although a number of molecules on phagocytes have been found to be involved in apoptotic cell clearance in vitro, only a few have been proved to be involved in apoptotic cell clearance in vivo by analyses of knockout animals. These knockout mice commonly suffer from autoimmunity, indicating that the complete removal of apoptotic cells is essential for the maintenance of selftolerance. In this review, we present an overview of the molecular mechanisms of apoptotic cell clearance by phagocytes and the pathological relevance of the failure of apoptotic cell clearance to autoimmune disorder.
Export Options
About this article
Cite this article as:
Tanaka Masato and Miyake Yasunobu, Apoptotic Cell Clearance and Autoimmune Disorder, Current Medicinal Chemistry 2007; 14 (27) . https://dx.doi.org/10.2174/092986707782360006
DOI https://dx.doi.org/10.2174/092986707782360006 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current and Future Therapeutic Strategies to Target Inflammation in Stroke
Current Drug Targets - Inflammation & Allergy Th17 and Treg Cells, Two New Lymphocyte Subpopulations with a Key Role in the Immune Response Against Infection
Infectious Disorders - Drug Targets Immunomodulation and Anti-inflammatory Roles of Polyphenols as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry IL-27: Friend or Foe in the Autoimmune Diseases
Current Immunology Reviews (Discontinued) Boosting Interleukin-10 Production: Therapeutic Effects and Mechanisms
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Synthetic Glycolipid Ligands for Human iNKT Cells as Potential Therapeutic Agents for Immunotherapy
Current Medicinal Chemistry Vaccine Development for Alzheimers Disease
Current Pharmaceutical Design The Innate Immunity in Alzheimer Disease- Relevance to Pathogenesis and Therapy
Current Pharmaceutical Design Stem Cells Derived from Human Exfoliated Deciduous Teeth (SHED) in Neuronal Disorders: A Review
Current Stem Cell Research & Therapy Gene Therapy for Neuroprotection and Neurorestoration (Part I)
Current Gene Therapy Neuroinflammation in Sepsis: Sepsis Associated Delirium
Cardiovascular & Hematological Disorders-Drug Targets Down Regulated Expression of Claudin-1 and Claudin-5 and Up Regulation of β-Catenin: Association with Human Glioma Progression
CNS & Neurological Disorders - Drug Targets Histone Deacetylase Inhibitors: New Promise in the Treatment of Immune and Inflammatory Diseases
Current Drug Targets Targeting Microglial Polarization to Improve TBI Outcomes
CNS & Neurological Disorders - Drug Targets Use of MHC II Structural Features in the Design of Vaccines for Organ-Specific Autoimmune Diseases
Current Pharmaceutical Design Design, Synthesis, and Anti-Neuroinflammatory Activity of Amide- Containing Dithiolethiones
Medicinal Chemistry Therapeutic Peptide Mimetics Looking for a Turn to Block Aberrant Players of Malignancy
Current Cancer Therapy Reviews Oxidative Stress, Pro-Inflammatory Cytokines, and Antioxidants Regulate Expression Levels of MicroRNAs in Parkinson’s Disease
Current Aging Science Diabetes Mellitus: Channeling Care through Cellular Discovery
Current Neurovascular Research Nerve Growth Factor and Brain-Derived Neurotrophic Factor in Schizophrenia and Depression: Findings in Humans, and Animal Models
Current Neuropharmacology